NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Deepak Nitrite Subsidiary Partners with Praxair India for HyCO Plant to Support Polycarbonate Project
Deepak Chem Tech Limited (DCTL), a wholly-owned subsidiary of Deepak Nitrite, has signed a long-term agreement with Praxair India (a Linde company) to build a HyCO plant. This facility will supply essential raw materials for DCTL's upcoming Polycarbonate manufacturing plant in Dahej, Gujarat. Under the agreement, Praxair will build, own, and operate the facility, ensuring a reliable feedstock supply for the project. The plant is expected to be commissioned in 2028, aligning with the timeline for the Polycarbonate project's launch.
முக்கிய அம்சங்கள்
Long-term agreement with Praxair India (Linde) for a dedicated on-site HyCO plant at Dahej.Secures critical raw material supply for the upcoming Polycarbonate manufacturing facility.Facility to be built, owned, and operated by Praxair India, enhancing operational efficiency.Commissioning of the HyCO plant is scheduled for 2028, matching the Polycarbonate plant's timeline.Targets high-growth domestic segments including automotive, electronics, and construction.
👀 கவனிக்க வேண்டியவை
Investors should view this as a strategic de-risking move that secures the supply chain for a major growth project. Monitor the capital expenditure and execution progress of the Polycarbonate facility leading up to 2028.
Deepak Nitrite Subsidiary DCTL Raises ₹150 Cr from Deepak Phenolics via OCRPS
Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited (DCTL), has raised ₹150 Crores through the allotment of 1.5 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS). The funds were provided by Deepak Phenolics Limited (DPL), another wholly-owned subsidiary, representing an internal capital reallocation within the group. This infusion is designed to strengthen DCTL's capital base and support its ongoing project expenses in specialized segments like Fluorination and Nitration. DCTL is currently in a scaling phase, with turnover growing from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.
முக்கிய அம்சங்கள்
Allotment of 1,50,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at ₹100 each.Total capital infusion of ₹150 Crores sourced internally from Deepak Phenolics Limited.Funds targeted for project expenses and strengthening the capital base of DCTL's chemical operations.DCTL's turnover showed significant growth to ₹9.43 Crores in FY 2024-25 from ₹0.86 Crores in FY 2023-24.Post-allotment, Deepak Nitrite continues to maintain 100% effective control over DCTL.
👀 கவனிக்க வேண்டியவை
Investors should view this as a routine internal capital allocation to support the growth of a nascent subsidiary; focus should remain on the execution of DCTL's Fluorination and Nitration projects.
Deepak Nitrite Infuses ₹135 Cr into Subsidiary Deepak Chem Tech for Project Expansion
Deepak Nitrite (DNL) and its subsidiary Deepak Phenolics (DPL) have collectively invested ₹135 Crores into Deepak Chem Tech Limited (DCTL). The investment was made through the allotment of 1.35 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at ₹100 each. These funds are intended to strengthen DCTL's capital base and support its ongoing projects in Fluorination, Nitric Acid, and Nitration. DCTL is a growing subsidiary, with its turnover increasing from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.
முக்கிய அம்சங்கள்
Total capital infusion of ₹135 Crores into wholly-owned subsidiary Deepak Chem Tech Limited.Issuance of 1.10 crore OCRPS to Deepak Phenolics and 25 lakh OCRPS to Deepak Nitrite at ₹100 par value.Funds will support project expenses for Fluorination, Nitric Acid, Nitration, and Hydrogenation plants.DCTL's turnover showed significant growth, reaching ₹9.43 Crores in FY 2024-25.The 9% OCRPS are designed to provide flexible capital structure for the subsidiary's expansion in Gujarat.
👀 கவனிக்க வேண்டியவை
Investors should monitor the commissioning of DCTL's specialized chemical plants as they represent a key growth vertical for the group. The internal funding demonstrates the parent company's strong cash position and commitment to high-margin chemical segments.
Deepak Nitrite Subsidiary DPL Invests ₹100 Crore in Deepak Chem Tech via OCRPS
Deepak Nitrite's wholly-owned subsidiary, Deepak Phenolics Limited (DPL), has invested ₹100 Crores into another subsidiary, Deepak Chem Tech Limited (DCTL). The investment was executed through the allotment of 1 crore 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at par value. This capital infusion is designed to strengthen DCTL's capital base and fund ongoing project expenses. DCTL is currently scaling its fluorination plant operations and pursuing multiple projects across Gujarat.
முக்கிய அம்சங்கள்
Deepak Phenolics Limited invested ₹100 Crores in Deepak Chem Tech Limited via 9% OCRPS.DCTL's turnover increased significantly from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.The funds are earmarked for project expenses and general corporate purposes within the fluorination segment.Deepak Nitrite continues to maintain 100% indirect control over DCTL's preference share capital.DCTL operates a state-of-the-art fluorination plant and is expanding its footprint in Gujarat.
👀 கவனிக்க வேண்டியவை
This is an internal capital reallocation to support the high-growth fluorination business; investors should track DCTL's project execution as it scales from a low revenue base. No immediate impact on consolidated financials is expected, but it signals long-term expansion in specialized chemicals.
Deepak Nitrite reported a steady Q3 FY26 with consolidated revenue rising 3% YoY to ₹1,983 crore, driven by higher volumes despite global pricing pressures. EBITDA increased 16% YoY to ₹219 crore, with margins improving to 11% due to operational efficiencies and vertical integration. While the Phenolics segment saw a 20% YoY EBIT growth, the Advanced Intermediates segment faced margin compression from aggressive Chinese competition. The company is nearing the commissioning of its MIBK/MIBC project and is progressing on its transformational polycarbonate plant.
முக்கிய அம்சங்கள்
Consolidated Q3 revenue reached ₹1,983 crore, up 3% YoY, with EBITDA rising 16% to ₹219 crore.Phenolics segment EBIT grew 20% YoY to ₹145 crore, while Advanced Intermediates revenue rose 18% to ₹652 crore.Commissioned new nitric acid and nitration plants, completing vertical integration for the ammonia-to-amines value chain.MIBK/MIBC project targeted for commissioning in Q4 FY26; Polycarbonate project funding is in final stages.Maintained a strong balance sheet with a net worth of ₹5,651 crore and a consolidated ROCE of 15%.
👀 கவனிக்க வேண்டியவை
Investors should focus on the successful ramp-up of newly commissioned capacities and the upcoming MIBK/MIBC project which are expected to improve margins. The company's strategy of vertical integration and import substitution makes it a resilient long-term play in the specialty chemicals space.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Deepak Nitrite Q3 FY26: EBITDA Grows 16% YoY to ₹219 Cr; US Removes 45% Sodium Nitrite Duty
Deepak Nitrite reported a resilient Q3 FY26 with consolidated revenue of ₹1,983 crore, a 3% YoY increase, and EBITDA growth of 16% YoY to ₹219 crore. The Phenolics segment drove profitability with a 20% YoY EBIT increase to ₹145 crore, while Advanced Intermediates faced pricing pressure from Chinese dumping despite 18% revenue growth. A significant regulatory tailwind emerged as the US removed a 45.16% Anti-Dumping Duty on the company's Sodium Nitrite exports. The company is also advancing its 165,000 MT Polycarbonate project and expects MIBK/MIBC commissioning in Q4 FY26.
முக்கிய அம்சங்கள்
Q3 FY26 Revenue rose 3% YoY to ₹1,983 crore, while EBITDA increased 16% YoY to ₹219 crore.US Department of Commerce removed 45.16% Anti-Dumping Duty on Sodium Nitrite exports effective January 2026.Phenolics segment EBIT grew 20% YoY to ₹145 crore supported by higher volumes and operating efficiencies.Completed vertical integration across the ammonia-nitration-amines chain with new Nitric Acid plant commissioning.MIBK/MIBC project targeted for Q4 FY26 commissioning; Polycarbonate plant relocation from Germany is on schedule.
👀 கவனிக்க வேண்டியவை
Investors should focus on the margin expansion potential from the newly commissioned backward integration plants and the removal of US export duties. While Chinese competition remains a headwind, the company's shift toward high-value specialty materials like Polycarbonate offers long-term growth prospects.
Deepak Nitrite Q3 Results: Consolidated PAT flat at ₹100 Cr; Revenue up 4% YoY
Deepak Nitrite reported a marginal 3.7% YoY growth in consolidated revenue to ₹1,975 Cr for Q3 FY26, while consolidated net profit remained nearly flat at ₹100 Cr. The standalone business saw strong revenue growth of 25.7% YoY but suffered a significant profit decline due to an exceptional provision of ₹10.51 Cr for new labor codes and higher material costs. The Phenolics segment, a major contributor, saw a slight revenue dip but maintained steady segment results. Overall 9-month performance remains under pressure with a 33% decline in consolidated net profit compared to the previous year.
முக்கிய அம்சங்கள்
Consolidated Revenue from operations grew 3.7% YoY to ₹1,974.97 Cr from ₹1,903.40 Cr.Consolidated Net Profit stood at ₹99.82 Cr, up marginally from ₹98.13 Cr in the same quarter last year.Exceptional item of ₹12.84 Cr (Consolidated) recognized due to the implementation of New Labour Codes.Advanced Intermediates segment revenue increased to ₹652.45 Cr from ₹551.69 Cr YoY.9-month consolidated PAT fell to ₹330.83 Cr from ₹494.85 Cr in the prior year period.
👀 கவனிக்க வேண்டியவை
The results show a stabilization in quarterly performance, but long-term growth remains muted compared to last year. Investors should monitor the recovery in the Phenolics segment and the impact of raw material price volatility on margins.
Deepak Nitrite Q3 FY26 Consolidated Net Profit Rises 21% YoY to ₹118.75 Crore
Deepak Nitrite reported a steady performance for Q3 FY26, with consolidated revenue growing 3.8% YoY to ₹1,974.97 crore. Consolidated net profit increased significantly by 21% YoY to ₹118.75 crore, despite an exceptional charge of ₹12.84 crore related to the New Labour Codes. The Phenolics segment remains the primary driver, contributing ₹1,333.79 crore to revenue and ₹145.32 crore to segment results. Advanced Intermediates showed revenue growth but lower margins compared to the previous quarter.
முக்கிய அம்சங்கள்
Consolidated Net Profit grew 21% YoY to ₹118.75 Cr, overcoming an exceptional cost of ₹12.84 Cr.Total Consolidated Revenue reached ₹1,974.97 Cr, up from ₹1,903.40 Cr in the same quarter last year.Phenolics segment EBIT stood strong at ₹145.32 Cr on revenue of ₹1,333.79 Cr.Advanced Intermediates segment revenue grew to ₹652.45 Cr, though segment results dipped to ₹14.94 Cr.Company recognized an exceptional item of ₹12.84 Cr due to the implementation of New Labour Codes.
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustained performance of the Phenolics division and the margin recovery in Advanced Intermediates. The stock remains a solid play in the specialty chemicals space given the healthy year-on-year profit growth.
Deepak Nitrite Subsidiary DPL Invests ₹80 Crore in Deepak Chem Tech via Preference Shares
Deepak Phenolics Limited (DPL), a wholly owned subsidiary of Deepak Nitrite, has invested ₹80 Crores into another subsidiary, Deepak Chem Tech Limited (DCTL). The investment was executed through the allotment of 80,00,000 9% Optionally Convertible Redeemable Preference Shares (OCRPS) at ₹100 each. This internal capital infusion is designed to strengthen DCTL's capital base and fund its ongoing project expenses, particularly for its Fluorination plant. DCTL is showing early growth signs, with turnover rising from ₹0.86 Crores in FY24 to ₹9.43 Crores in FY25.
முக்கிய அம்சங்கள்
Allotment of 80,00,000 9% OCRPS at par, aggregating to ₹80 CroresDCTL turnover grew significantly to ₹9.43 Crores in FY 2024-25 from ₹0.86 Crores in FY 2023-24Funds earmarked for DCTL's state-of-the-art Fluorination plant and other Gujarat-based projectsDeepak Nitrite maintains 100% control over both subsidiaries involved in the transactionDCTL's total paid-up capital prior to this allotment stood at ₹1,919.50 Crores
👀 கவனிக்க வேண்டியவை
This is an internal capital reallocation to support the company's expansion into specialized chemical segments like Fluorination. Investors should view this as a commitment to long-term growth in high-margin verticals, though it has no immediate impact on consolidated financials.
Deepak Nitrite's wholly-owned subsidiary, Deepak Chem Tech Limited, has successfully commissioned its Nitration and 2nd Hydrogenation Plant at Dahej, Gujarat. The project involved a total capital expenditure of approximately ₹85 Crores as of the commissioning date on January 19, 2026. This expansion is expected to enhance the company's chemical processing capabilities and downstream integration. The timely commissioning of this facility reflects the company's focus on scaling its specialty chemicals portfolio.
முக்கிய அம்சங்கள்
Commissioning of Nitration and 2nd Hydrogenation Plant at Dahej, Dist. Bharuch, Gujarat.Total capital expenditure incurred for the project is approximately ₹85 Crores.The facility is operated by Deepak Chem Tech Limited, a material wholly-owned subsidiary.The plant was officially commissioned on January 19, 2026.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive step towards capacity expansion and monitor the subsequent impact on revenue growth in the specialty chemicals segment. No immediate action is required, but the development strengthens the long-term growth thesis.
Deepak Chem Tech Limited, a wholly owned subsidiary of Deepak Nitrite, has commenced manufacturing operations at its Nitric Acid Plant in Nandesari, Gujarat, as of December 4, 2025. The project involved a total capital expenditure of approximately ₹515 Crores. This strategic move strengthens the group's backward and forward integration, enhancing supply security for key intermediates. The facility allows the group to evolve into a more integrated chemical platform, spanning from Ammonia to Amines.
முக்கிய அம்சங்கள்
Commencement of Nitric Acid Plant operations at Nandesari, Gujarat, on December 4, 2025.Total capital expenditure for the project is approximately ₹515 Crores.Strengthens backward and forward integration, reinforcing supply security for key intermediates.Enables deeper penetration into high-value applications and enhances resilience.Positions the group as an integrated platform from Ammonia to Amines, a capability held by few global players.
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development for long-term margin expansion and supply chain stability. Monitor the plant's ramp-up and its contribution to the company's specialty chemical segment in upcoming quarters.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
